Sign in

Trial result ·

Heyndrickxia coagulans IDCC 1201 Alters Gut Microbiome and Metabolome in Patients with Functional Bowel Disorders.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

Researchers tested Heyndrickxia coagulans IDCC 1201, called COA 1201 here. The people were adults with functional bowel disorders, which are long-lasting gut problems. People were put into groups by chance. One group took COA 1201 for 8 weeks. The other group took a dummy product, called a placebo. Neither the people nor the staff knew who got which. The team scored symptoms, quality of life and bowel habits. They also checked stool samples for gut germs and body chemicals.

What they found

Both groups felt better than at the start. Symptom relief was greater in the COA 1201 group. This was clearest for bloating and for discomfort after a bowel movement. Body image scores also improved more with COA 1201. The overall mix of gut germs changed only a bit. Some germs that break down sugars rose with COA 1201. These included Ruminococcus bromii, Agathobacter rectalis and Bifidobacterium. Clostridium leptum rose in the placebo group instead. Stool chemical patterns were not the same in the groups. Tryptophan, lactic acid and phytosphingosine were tied to COA 1201.

What it means for patients

The authors suggest COA 1201 may ease symptoms of these bowel problems. They think it may work by changing gut germs and body chemicals. The abstract puts this as a suggestion, not as firm proof.

Why it is not certain yet

The abstract does not say how many people took part. It does not give the size of the symptom changes. The study lasted 8 weeks, so longer effects are not known. The authors call the stool chemical findings exploratory. The abstract does not describe side effects.

Source

Heyndrickxia coagulans IDCC 1201 Alters Gut Microbiome and Metabolome in Patients with Functional Bowel Disorders.

PubMed · PMID 42588089

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Irritable bowel syndrome publications